- 同
- HBeAg
- 同
- HBeAg
WordNet
- the 2nd letter of the Roman alphabet (同)b
- the blood group whose red cells carry the B antigen (同)type_B, group B
- any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)
- inflammation of the liver caused by a virus or a toxin
- the 5th letter of the Roman alphabet (同)e
- the base of the natural system of logarithms; approximately equal to 2.718282...
PrepTutorEJDIC
- 抗原(生物の体内にはいって免疫体を作る物質)
- 肝[臓]炎
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. B型肝炎ウイルス感染の診断 diagnosis of hepatitis b virus infection
- 2. 小児および思春期におけるB型肝炎ウイルス感染の概要 overview of hepatitis b virus infection in children and adolescents
- 3. HIV感染患者における慢性B型慢性肝炎ウイルス感染の治療前評価 pretreatment evaluation of chronic hepatitis b virus infection in the hiv infected patient
- 4. 慢性B型肝炎ウイルスに感染したHIV感染患者のモニタリング monitoring the hiv infected patient with chronic hepatitis b virus infection
- 5. 慢性B型肝炎ウイルス感染に対する肝移植 liver transplantation for chronic hepatitis b virus infection
English Journal
- Modulation of the antioxidant/pro-oxidant balance, cytotoxicity and antiviral actions of grape seed extracts.
- Ignea C, Dorobanţu CM, Mintoff CP, Branza-Nichita N, Ladomery MR, Kefalas P, Chedea VS.SourceDepartment of Food Quality and Chemistry of Natural Products, Mediterranean Agronomic Institute of Chania, Centre International de Hautes Etudes Agronomiques Méditerranéennes, Chania, PO Box 85, 73100 Chania, Crete, Greece. igneacodruta@yahoo.com
- Food chemistry.Food Chem.2013 Dec 15;141(4):3967-76. doi: 10.1016/j.foodchem.2013.06.094. Epub 2013 Jun 29.
- Grape seed extracts (GSEs) were investigated in yeast cells harbouring defects in their antioxidant system (regarding the cellular growth and growth recovery from H2O2 insult). GSEs antioxidant activity was detected in wild-type and mutant strains Δcta1, Δgsh1 and Δoye2glr1, while pro-oxidant act
- PMID 23993573
- Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen-Negative Patients With Chronic Hepatitis.
- Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA.SourceDepartment of Hepatobiliary Sciences and Liver Transplantation, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Liver Disease Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: sanaifa@ngha.med.sa.
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.Clin Gastroenterol Hepatol.2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.
- BACKGROUND & AIMS: Differing threshold levels of hepatitis B virus (HBV) DNA and alanine aminotransferase (ALT) are recommended by international guidelines for commencement of antiviral therapy. These guidelines advocate therapy for patients with significant fibrosis (METAVIR score ≥F2); we as
- PMID 23811251
- Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: A prospective cohort study with paired transient elastography examination.
- Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW.SourceInstitute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Journal of gastroenterology and hepatology.J Gastroenterol Hepatol.2013 Nov;28(11):1762-9. doi: 10.1111/jgh.12312.
- BACKGROUND AND AIM: Chronic hepatitis B patients in immune-reactive hepatitis B e antigen (HBeAg)-positive phase may have more rapid progression than those in immune-tolerant phase. We aimed to evaluate the risk of liver fibrosis progression in HBeAg-positive patients at different phases.METHODS: Tw
- PMID 23808759
Japanese Journal
- 症例報告 肝発癌後にPeg-IFNα-2a投与によりHBs抗原陰性化 : HBs抗体陽性化が得られたB型慢性肝炎の1例
- 肝臓 57(12), 666-673, 2016-12
- NAID 40021041765
- 妊婦健診における肝炎ウイルス検査に対する意識調査
- 肝臓 57(8), 376-381, 2016-08
- NAID 40020912417
- Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients
- Acta Medica Okayama 70(1), 1-12, 2016-02
- NAID 120005712600
Related Links
- hepatitis B e antigen n. Abbr. HBe, HB e Ag A core protein antigen of the hepatitis B virus distinct from hepatitis B core antigen, associated with infectivity. antigen [an´tĭ-jen] any substance capable, under appropriate conditions, of ...
- antigen: see immunity immunity, ability of an organism to resist disease by identifying and destroying foreign substances or organisms. Although all animals have some immune capabilities, little is known about nonmammalian ...
Related Pictures
★リンクテーブル★
| リンク元 | 「HBe抗原」「B型肝炎e抗原」「HBeAg」 |
| 関連記事 | 「B」「E」 |
「HBe抗原」
- ウイルスのコアのタンパク質が抗原性を有する
- ウイルス内部の構造に対する抗体なので、中和抗体ではない
- HBc抗原とは異なる部位である
- 発症した後に上昇する
- ウイルスの複製が盛んな時に上昇する。
- 高値の時には感染力が強い。
- HBe抗原とHBV-DNAの量は相関している。
「B型肝炎e抗原」
-HBeAg
- 同
- hepatitis B "e" antigen
「HBeAg」
[★] HBe抗原、B型肝炎e抗原、hepatitis B e antigen
「B」
- 気管分岐部下緑
- 補体のalternative pathwayに関わる蛋白質
- Mg2+存在下でC3, B, Dが反応してC3bBbとなり、これがC3転換酵素(C3bBb)あるいはC5転換酵素(C3bBb3b)を形成する。これらはP(properdin)と結合して活性化し、それぞれC3、C5を活性化する
「E」